JPRN-UMIN000039937已完成未知
Evaluation of the safety and efficacy of continuous use of skincare formulations - Evaluation of the safety and efficacy of continuous use of skincare formulations
Beauty & Health Research Inc.0 个研究点目标入组 46 人开始时间: 2020年3月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)Subjects who have a facial injury 2)Those who used a medicinal product that can potentially affect the study within 3 months of the start of the study or who will probably use a drug that can potentially affect the results during the study period 3)Subjects who underwent a cosmetic procedure such as collagen or hyaluronic acid injection, botox injection, chemical peeling, laser therapy, or phototherapy within 6 months of the start of the study or who will probably undergo one of the above-mentioned cosmetic procedures during the study period 4)Those currently receiving hormone replacement therapy or who will probably receive hormone replacement therapy during the study period 5)Those who will probably experience substantial exposure to sunlight during the study 6)Those who have previously developed serious skin problems arising from the use of cosmetic products or other similar products 7)Those who have previously developed dermatitis due to adhesive tape or other similar products 8)Subjects whose face is affected by atopic dermatitis or another skin disease 9)Those who suffer from severe hay fever 10)Those who habitually consume excess amounts of alcohol 11)Those who are unable to discontinue drugs that can potentially affect the study results 12)Those who have a history of severe liver disease, kidney disease, myocardial infarction, or other similar serious conditions and who will probably start to receive a new treatment at a medical institution during the study period 13)Those who suffer from severe anemia 14)Those who are pregnant or will potentially become pregnant during the study or who are breast-feeding 15)Those who will have participated in another clinical study between 3 months before screening and the end of this study or will probably participate in another clinical study during this study period 16)Subjects whose enrollment in the study is considered inappropriate by the principal investigator
研究者
相似试验
已完成
不适用
Evaluation of the safety and efficacy of continuous use of skincare formulationsHealthyJPRN-UMIN000039938Beauty & Health Research Inc.45
尚未招募
不适用
To evaluate the efficacy and safety of regional block of the abdomen( between 2 muscles) using ultrasound guidance after laparoscopic nephrectomy surgery - a clinical trialCTRI/2020/03/023760All India Institute of Medical Sciences Jodhpur
招募中
不适用
Intravenous Labetalol for intracerebral hemorrhageBlood pressure control and hematoma volume control in patients with spontaneous intracerebral hemorrhageLabetalolblood pressurehemorrhagic strokeintracranial hemorrhageTCTR20240423003Faculty of Medicine, Thammasat University100
招募中
2 期
Assessment of efficacy and safety of continouation maintenance therapy with gemcitabine after cisplatin-gemcitabine induction chemotherapy in advanced squamous cell lung cancer (KTORG1302)squamous cell lung cancerJPRN-UMIN000010721Kyoto Thoracic Oncology Research Group (KTORG)60
尚未招募
3 期
A clinical trial to study the effects of two drugs, sustained release and immediate release mucoregulator in patients with bronchial asthma.CTRI/2010/091/000571Sun Pharmaceutical Industries Ltd.200